27.10.2021 | Letter to the Editor
Authors’ reply to Borg and Thoning: “Comment on: Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study”
Erschienen in: American Journal of Clinical Dermatology | Ausgabe 6/2021
Einloggen, um Zugang zu erhalten